Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
Enrique Crisman, Pablo Duarte, E. Daudén, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 237-287
Open Access | Times Cited: 120

Showing 26-50 of 120 citing articles:

Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
Xiaoning Gao, WuYan Guo, Peiyuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Carnitine functions as an enhancer of NRF2 to inhibit osteoclastogenesis via regulating macrophage polarization in osteoporosis
Tao Yang, Shijie Liu, Haiwei Ma, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 174-189
Closed Access | Times Cited: 5
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor
Kazuki Otake, Minoru Ubukata, Noboru Nagahashi, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 658-665
Open Access | Times Cited: 12
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 12
Nrf2 activation improves experimental rheumatoid arthritis
Anqi Zhang, Takafumi Suzuki, Saki Adachi, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 279-295
Open Access | Times Cited: 11
In vitro and in silico perspectives on the activation of antioxidant responsive element by citrus-derived flavonoids
Tianzhu Guan, Canfeng Bian, Zheng Ma
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 11
Bomidin attenuates inflammation of periodontal ligament stem cells and periodontitis in mice via inhibiting ferroptosis
Wei Wu, Guoqing Li, Shuo Dong, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111423-111423
Closed Access | Times Cited: 11
Mesenchymal stem cells inhibit ferroptosis by activating the Nrf2 antioxidation pathway in severe acute pancreatitis-associated acute lung injury
Hongfang Yang, Yan Liu, Jiaqi Yao, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176380-176380
Open Access | Times Cited: 4
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 4
Methyl 3,4-dihydroxybenzoate alleviates oxidative damage in granulosa cells by activating Nrf2 antioxidant pathway
Shishi Li, Yuhang Fan, Chongyi Shu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Brigitta Buttari, Antonella Tramutola, Ana I. Rojo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 113-113
Open Access
Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1N532/M550 and promoting its degradation
Ying Zhang, Huan Lan, Wenjuan Zhai, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101219-101219
Open Access
Therapeutic Effects of Natural Products in the Treatment of Chronic Diseases: The Role in Regulating KEAP1–NRF2 Pathway
Yaling Li, Xihua Wang, Shuyue Li, et al.
The American Journal of Chinese Medicine (2025), pp. 1-30
Closed Access
Sesquiterpene lactones from Cichorium intybus exhibit potent anti-inflammatory and hepatoprotective effects by repression of NF-κB and enhancement of NRF2
Yan Zhou, Tian Wen, Shan Yang, et al.
Journal of Ethnopharmacology (2025) Vol. 343, pp. 119439-119439
Closed Access
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Clinical Assessment of the Drug–Drug Interaction Potential of Omaveloxolone in Healthy Adult Participants
Hamim Zahir, Masako Murai, Lucy Wu, et al.
The Journal of Clinical Pharmacology (2025)
Open Access
Serum amyloid A drive microglia shift to a resolving phenotype through Nrf2
Qi Li, Yiwei Huang, Tao Ban, et al.
Neuropharmacology (2025), pp. 110374-110374
Closed Access
MS-275 facilitates osseointegration in osteoporotic rats by mitigating oxidative stress via activation of the miR-200a/Keap1/Nrf2 signaling pathway
Junjie Yan, Qiang Gu, Jianqiao Li, et al.
Redox Report (2025) Vol. 30, Iss. 1
Open Access
A novel KEAP1 inhibitor, tiliroside, activates NRF2 to protect against acetaminophen-induced oxidative stress and acute liver injury
Fangfang Cai, Kaiqian Zhou, Peipei Wang, et al.
Hepatology Communications (2025) Vol. 9, Iss. 3
Open Access
Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
Xiaoning Gao, WuYan Guo, Peiyuan Liu, et al.
(2025)
Open Access
Exploring the structural properties, osteoarthritis-relieving effects and potential mechanisms of peptides from eggshell membrane byproduct
Lingjiao Zhu, Meihu Ma, Wei Xu, et al.
Food Bioscience (2025), pp. 106243-106243
Closed Access
RoseTTAFold diffusion-guided short peptide design: a case study of binders against Keap1/Nrf2
Francesco Morena, Chiara Cencini, Carla Emiliani, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 896-911
Open Access
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell lines
Laura Naldi, Martina Catalano, Maria Elena Melica, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Frontier Exploration of Algorithm Innovation and Experimental Verification in Intelligent Protein Design
Yi Sui
Scientific Journal of Technology (2025) Vol. 7, Iss. 3, pp. 55-62
Closed Access
Erianin alleviates doxorubicin-induced cardiotoxicity by activating the Keap1-Nrf2 signaling pathway
Shiyao Kang, Huimin Li, Ming Li, et al.
Phytomedicine (2025), pp. 156684-156684
Closed Access

Scroll to top